By www.reliableresearchtimes.com
Global Gastroesophageal Reflux Disease (GERD) Drugs And Devices Key Trends And Opportunities To 2031 Story
170
$ 6600
Gastroesophageal Reflux Disease (GERD) Drugs And Devices Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
AstraZeneca, Plc.
Addex Therapeutics
Takeda Pharmaceutical Company Limited
Rottapharm (Meda AB)
Pfizer, Inc.
Eisai Co. Ltd.
The Procter & Gamble Company
Mederi Therapeutics
Aros Pharma
Torax Medical, Inc.
BD
EndoGastric Solutions
Medigus Ltd.